Jennifer C. Smith-Parker, Director of Insights at BioSpace, hosted a discussion with Viswa Colluru, CEO and founder of Enveda, and Akshay Rai, principal for Healthcare and Biotech Investments at Premji Invest, according to a Mar. 19 episode of the Denatured podcast.
The conversation focused on the competitive landscape of artificial intelligence platforms in drug discovery. The speakers addressed how data quality, valuable assets, and positive clinical outcomes are key factors for attracting investor interest in this rapidly evolving sector.
Colluru and Rai shared their perspectives on what makes an AI platform stand out to investors. They discussed the importance of demonstrating real-world results and building robust datasets that can support innovative drug development efforts.
Smith-Parker guided the discussion by asking about challenges faced by companies working at the intersection of technology and biotechnology. The guests highlighted both opportunities and hurdles as organizations race to develop next-generation solutions for healthcare.
A disclaimer noted that "the views expressed in this discussion by guests are their own and do not represent those of their organizations." This statement emphasized that opinions shared during the podcast reflect individual viewpoints rather than official positions.
